Richard Newitter
Stock Analyst at Truist Securities
(4.14)
# 543
Out of 5,046 analysts
403
Total ratings
52.48%
Success rate
13.04%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterates: Buy | $28 → $32 | $27.22 | +17.56% | 4 | Oct 29, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $82 → $87 | $82.45 | +5.52% | 20 | Oct 28, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $121 → $88 | $64.57 | +36.29% | 10 | Oct 24, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $129 → $130 | $100.72 | +29.07% | 19 | Oct 23, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $525 → $620 | $534.28 | +16.04% | 31 | Oct 22, 2025 | |
| VCEL Vericel | Maintains: Buy | $46 → $41 | $35.06 | +16.94% | 4 | Oct 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $14 → $16 | $14.00 | +14.29% | 2 | Oct 15, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $8 → $7 | $6.39 | +9.55% | 16 | Oct 15, 2025 | |
| SYK Stryker | Maintains: Hold | $415 → $407 | $356.24 | +14.25% | 22 | Oct 15, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $64 → $50 | $34.03 | +46.93% | 15 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $300 | $227.37 | +31.94% | 6 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $96 → $103 | $90.70 | +13.56% | 17 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $205 | $187.30 | +9.45% | 17 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $125 → $90 | $72.08 | +24.86% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $12.01 | +24.90% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $94 | $58.22 | +61.46% | 2 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $126 → $120 | $88.07 | +36.26% | 6 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $12.93 | +39.21% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $111 → $63 | $57.69 | +9.20% | 19 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $365 | $313.01 | +16.61% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $68 | $60.39 | +12.60% | 27 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $124.47 | +10.07% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $16.84 | +42.52% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $100.56 | +12.37% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $14.83 | +41.60% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.79 | +127.53% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $73.89 | +10.98% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $178.71 | +39.89% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.25 | +511.76% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $137.88 | +458.46% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $73.91 | +15.00% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.31 | +62.47% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $22.22 | +21.51% | 5 | Feb 23, 2021 |
Beta Bionics
Oct 29, 2025
Reiterates: Buy
Price Target: $28 → $32
Current: $27.22
Upside: +17.56%
Edwards Lifesciences
Oct 28, 2025
Maintains: Hold
Price Target: $82 → $87
Current: $82.45
Upside: +5.52%
Integer Holdings
Oct 24, 2025
Maintains: Buy
Price Target: $121 → $88
Current: $64.57
Upside: +36.29%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $129 → $130
Current: $100.72
Upside: +29.07%
Intuitive Surgical
Oct 22, 2025
Maintains: Buy
Price Target: $525 → $620
Current: $534.28
Upside: +16.04%
Vericel
Oct 15, 2025
Maintains: Buy
Price Target: $46 → $41
Current: $35.06
Upside: +16.94%
Tandem Diabetes Care
Oct 15, 2025
Maintains: Hold
Price Target: $14 → $16
Current: $14.00
Upside: +14.29%
Treace Medical Concepts
Oct 15, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $6.39
Upside: +9.55%
Stryker
Oct 15, 2025
Maintains: Hold
Price Target: $415 → $407
Current: $356.24
Upside: +14.25%
PROCEPT BioRobotics
Oct 15, 2025
Maintains: Buy
Price Target: $64 → $50
Current: $34.03
Upside: +46.93%
Oct 15, 2025
Maintains: Buy
Price Target: $310 → $300
Current: $227.37
Upside: +31.94%
Oct 15, 2025
Maintains: Hold
Price Target: $96 → $103
Current: $90.70
Upside: +13.56%
Oct 15, 2025
Maintains: Buy
Price Target: $175 → $205
Current: $187.30
Upside: +9.45%
Oct 15, 2025
Maintains: Hold
Price Target: $125 → $90
Current: $72.08
Upside: +24.86%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $12.01
Upside: +24.90%
Oct 15, 2025
Maintains: Buy
Price Target: $102 → $94
Current: $58.22
Upside: +61.46%
Sep 22, 2025
Maintains: Buy
Price Target: $126 → $120
Current: $88.07
Upside: +36.26%
Aug 18, 2025
Initiates: Buy
Price Target: $18
Current: $12.93
Upside: +39.21%
Aug 12, 2025
Downgrades: Hold
Price Target: $111 → $63
Current: $57.69
Upside: +9.20%
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $313.01
Upside: +16.61%
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $60.39
Upside: +12.60%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $124.47
Upside: +10.07%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $16.84
Upside: +42.52%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $100.56
Upside: +12.37%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $14.83
Upside: +41.60%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.79
Upside: +127.53%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $73.89
Upside: +10.98%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $178.71
Upside: +39.89%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.25
Upside: +511.76%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $137.88
Upside: +458.46%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $73.91
Upside: +15.00%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.31
Upside: +62.47%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $22.22
Upside: +21.51%